K
1.40
+1.45%
Close of 9 Nov 2026, in HKD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in CNY, from our data supplier.
Revenue
—
FY2018FY2023
Net income
−CN¥1.06bn
FY2018FY2023
Free cash flow
−CN¥390.3m
FY2018FY2023
Shareholders' equity
—
FY2018FY2023
Income statement
Fiscal years
| FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|
| Revenue | — | — | CN¥34.2m | — | — | CN¥698,000 |
| Gross profit | −CN¥43.7m | — | CN¥34.2m | — | — | CN¥9,000 |
| Research and development | CN¥929.2m | CN¥818.6m | CN¥763.3m | CN¥325.4m | CN¥211.3m | CN¥93.2m |
| Operating income | −CN¥1.07bn | −CN¥969.1m | −CN¥834.7m | −CN¥399.7m | −CN¥230.7m | −CN¥109.6m |
| Net income | −CN¥1.06bn | −CN¥954.4m | −CN¥842.1m | −CN¥508.3m | −CN¥232.6m | −CN¥108.5m |
| Diluted earnings per share | -2.47 | -2.53 | -2.36 | -1.64 | -0.84 | -0.39 |
Balance sheet
At each fiscal year end
| FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|
| Total assets | — | CN¥2.06bn | CN¥2.07bn | CN¥1.85bn | CN¥553.4m | CN¥423.6m |
| Cash and short-term investments | — | CN¥875.3m | CN¥1.06bn | CN¥1.39bn | CN¥195.5m | CN¥137.5m |
| Total liabilities | — | CN¥559.9m | CN¥412.8m | CN¥343.5m | CN¥183.7m | CN¥171.9m |
| Debt | — | CN¥286.4m | CN¥159.7m | CN¥221.7m | CN¥64.1m | CN¥69.6m |
| Shareholders' equity | — | CN¥1.50bn | CN¥1.66bn | CN¥1.51bn | CN¥369.7m | CN¥251.7m |
| Shares outstanding | 429m | 377m | 356m | 309m | 277m | 277m |
Cash flow
Fiscal years
| FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|
| Cash from operations | −CN¥387.6m | −CN¥961.3m | −CN¥1.05bn | −CN¥380.9m | −CN¥228.0m | −CN¥114.9m |
| Capital spending | −CN¥2.7m | −CN¥27.6m | −CN¥105.7m | −CN¥96.2m | −CN¥74.1m | −CN¥19.4m |
| Free cash flow | −CN¥390.3m | −CN¥988.9m | −CN¥1.16bn | −CN¥477.0m | −CN¥302.2m | −CN¥134.3m |
Latest quarters
By quarter end
| Jun 2025 | Dec 2024 | Jun 2024 | Dec 2023 | Jun 2023 | Dec 2022 | Sept 2022 | Jun 2022 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥6.0m | CN¥5.0m | — | — | — | — | — | — |
| Gross profit | −CN¥196,000 | −CN¥5.9m | CN¥1.1m | −CN¥43.7m | — | — | — | — |
| Operating income | −CN¥81.2m | −CN¥83.8m | −CN¥71.3m | −CN¥853.2m | −CN¥216.5m | −CN¥435.3m | −CN¥220.6m | −CN¥533.8m |
| Net income | −CN¥83.3m | −CN¥83.8m | −CN¥71.5m | −CN¥848.7m | −CN¥212.1m | −CN¥435.9m | −CN¥218.0m | −CN¥518.4m |
| Diluted earnings per share | -0.19 | -0.19 | -0.17 | -1.98 | -0.50 | -1.12 | -0.56 | -1.42 |
| Total assets | CN¥391.9m | CN¥515.1m | CN¥739.5m | CN¥869.2m | CN¥1.87bn | CN¥2.06bn | CN¥2.06bn | CN¥1.75bn |
| Cash and short-term investments | CN¥52.9m | CN¥147.4m | CN¥333.8m | CN¥456.3m | CN¥701.9m | CN¥875.3m | CN¥877.0m | CN¥387.5m |
| Debt | CN¥41.1m | CN¥34.4m | CN¥79.9m | CN¥155.7m | CN¥257.8m | CN¥223.1m | CN¥223.1m | CN¥218.0m |
| Shareholders' equity | CN¥216.0m | CN¥294.1m | CN¥391.6m | CN¥458.1m | CN¥1.33bn | CN¥1.50bn | CN¥1.50bn | CN¥1.19bn |
Financial ratios
Data as of 5 Nov 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 24.6% | -94.6% | — | — | 100.0% | — | 1.3% | 28.5% | 74.6% |
| Operating margin | -527.6% | -2919.9% | — | — | -2452.8% | — | -14988395.4% | -9407.1% | -4039.4% |
| Net margin | -612.3% | -3105.8% | — | — | -2460.0% | — | -15542.1% | -9433.5% | -3718.3% |
| Return on equity | -109.5% | -52.8% | -231.6% | -63.8% | -50.9% | -33.7% | — | — | — |
| Return on assets | -58.7% | -30.1% | -122.0% | -46.4% | -40.7% | -27.5% | — | — | — |
| Free cash flow yield | -27.1% | -35.0% | -68.1% | -0.0% | -0.0% | -0.0% | — | — | — |
| Revenue growth | 553.6% | — | — | — | — | — | -99.9% | -66.4% | — |
| Earnings growth | 28.9% | -85.4% | 11.2% | 13.3% | 65.7% | 118.6% | — | — | — |
| Current ratio | 0.43x | 1.03x | 2.10x | 4.74x | 6.94x | 8.39x | — | — | — |
| Debt to equity | 0.47x | 0.45x | 0.55x | 0.19x | 0.09x | 0.14x | — | — | — |
| Equity ratio | 53.6% | 57.1% | 52.7% | 72.8% | 80.0% | 81.4% | — | — | — |
| Interest coverage | -44.88x | -15.74x | -110.39x | -118.37x | -336.65x | -99.81x | — | — | — |
| R&D as a share of sales | 267.4% | 1562.9% | — | — | 2.2% | — | 13352.1% | 9133.8% | 1612.4% |
| Buybacks as a share of market value | -7.6% | 0.1% | 99.9% | -6.5% | -5.2% | -39.3% | — | — | — |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | -47.3% | — | — |
| Operating income | -42.9% | -7.6% | — |
| Net income | -43.1% | -7.8% | — |
Valuation history
At each fiscal year end
| FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|
| Price to earnings | -2.3 | -0.6 | -3.4 | -4.5 | -1.6 |
| Price to sales | 72.4 | — | — | 110.9 | — |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.